22 Biopharma Stocks With Breakout Potential in 2012

Description:

According to Adam Feuerstein, "Drug approval decisions garner big headlines, but savvy and successful biotech investors know that making smart trading decisions ahead of important clinical trial results is the ticket to banking serious coin." Read more here.

>>Also: 6 Stocks to Play if the Market Tanks

>>Also: 3 Hot Stocks for a Sideways Market

Most Viewed Portfolios

View All

Articles

5 Dividend Stocks Ready to Give Investors a Raise

10.17.14 | 10:28 AM

BALTIMORE (Stockpickr) -- There's an important lesson to be learned from the 7.7% decline that the S&P 500 has made from its all-time highs last ...

4 Big Stocks on Traders' Radars

10.17.14 | 03:17 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter